Biopharma Shakti: India targets China dependence, patent cliff
New Delhi: There is much more to the ₹10,000-crore 'Biopharma Manufacturing Shakti' booster in the latest budget than meets the eye as it is underpinned by two key strategic goals shaped both by shifting geopolitics and Covid-era learnings. The …